Tool overview
Panacea is listed under Healthcare AI tools.
What is Panacea?
Panacea combines former FDA reviewers and regulatory consultants with purpose-built AI workflows. It supports life-sciences companies across strategy, pre-submission meetings, authoring, filing, and approval pathways for drugs, biologics, and medical devices.
Best for
Biotech and medical-device teams preparing complex FDA submissions
Who is it for?
Decision note
Suitable for evaluation after confirming final commercial terms, permissions, data handling, lifecycle status, and edit-screen aliases. Keep Needs Review enabled until a human verifies the published profile.
Key features
Regulatory strategy led by former FDA experts
End-to-end filing and submission support
Purpose-built AI for regulatory research and authoring
Milestone-based fixed pricing instead of hourly billing
Support across device, drug, and biologic pathways
Continuous expert oversight of AI-assisted work
Use cases
Planning an FDA regulatory pathway
Preparing 510(k) or De Novo submissions
Supporting IND, NDA, or BLA filings
Managing pre-submission meetings
Authoring and organizing regulatory evidence
Pros
- Combines AI workflows with experienced reviewers
- Pricing is fixed and milestone based
- Covers major FDA pathways
- Human experts retain oversight
Cons
- No standard public project price
- Engagement depends on consultant capacity and scope
- Regulatory outcomes cannot be guaranteed
Limitations
Panacea can accelerate regulatory work but cannot guarantee FDA clearance or approval. Clients remain responsible for complete evidence, truthful submissions, clinical and quality obligations, legal review, and final decisions with qualified regulatory professionals.
Pricing details
Billing options
Pricing note
Panacea uses fixed, milestone-based project pricing with no hourly billing or upfront payment before agreed deliverables. A free consultation is available, but no ongoing free plan, product trial, or standard public project amount is published.
Supported languages
- English
Please log in to join the discussion.